Single Injection of PV-10 Being Tested in the Treatment of Advanced Melanoma

“A new study underway at Moffitt Cancer Center in Tampa, Florida, is investigating whether an intralesional injection of PV-10 (a substance derived from Rose Bengal, a staining agent that has been used to assess eye damage), is effective in reducing tumors and the spread of cancer in patients with melanoma. Early clinical trials show PV-10 can boost immune response in melanoma tumors and in the bloodstream.”